The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 48 | — | 20.1x | Near average | |
Growth | 78 | 63.9% | 5.6% | Above average | |
Quality | 63 | 177.5% | 7.6% | Near average | |
Safety | 71 | 1.2x | 0.4x | Above average | |
Capital Return | 77 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Axsome Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Axsome Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Axsome stock shows a state of complete stability in analyst estimates over the past 30 days, with the average price target stabilizing at $255.81 based on a consensus of 14 analysts. This consistency reflects the markets' wait for new catalysts, especially with a price gap (Dispersion) between the minimum of $200 and the maximum of $302, indicating a variance in evaluating the speed of future revenue growth despite general optimism.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.